Authors
Loading...
Systematic review finds DOACs increase arterial thrombosis risk in antiphospholipid syndrome patients, suggesting caution.
Alfehaid et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: